Regional cerebral blood flow patterns and response to donepezil treatment in patients with Alzheimer's disease

被引:44
作者
Hanyu, H
Shimizu, T
Tanaka, Y
Takasaki, M
Koizumi, K
Abe, K
机构
[1] Tokyo Med Univ, Dept Geriatr Med, Shinjuku Ku, Tokyo 1600023, Japan
[2] Tokyo Med Univ, Dept Radiol, Tokyo 1600023, Japan
关键词
regional cerebral blood flow; single-photon emission computed tomography; frontal lobe; donepezil; Alzheimer's disease;
D O I
10.1159/000068785
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
We attempted to identify the characteristic patterns in regional cerebral blood flow (rCBF) of patients with Alzheimer's disease who responded to donepezil therapy. Sixty-one patients treated with donepezil were divided into two groups (responders and nonresponders) on the basis of changes in their Mini Mental State Examination (MMSE) scores from baseline to study endpoint. We analyzed single-photon emission computed tomography data (SPECT) at baseline using three-dimensional stereotactic surface projections and compared differences in rCBF between the two groups. Statistical maps showed a significantly lower rCBF of the lateral and medial frontal lobes in the nonresponders than in the responders. There was a significant inverse correlation between the relative rCBF reduction in the frontal lobe and the MMSE change. These results suggest that frontal function, as assessed by SPECT, affects the patient's response to treatment with donepezil. Measuring rCBF may aid in the selection of possible treatment responders. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 28 条
[1]  
[Anonymous], 1998, Co-Planar Stereotactic Atlas of the Human Brain
[2]  
Bartenstein P, 1997, J NUCL MED, V38, P1095
[3]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[4]   Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease [J].
Giacobini, E .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2000, 14 :S3-S10
[5]  
HANYU H, 1993, GERONTOLOGY, V39, P260
[6]   Reduction of regional cerebral blood flow and cognitive impairment in patients with Alzheimer's disease: Evaluation of an observer-independent analytic approach [J].
Hirsch, C ;
Bartenstein, P ;
Minoshima, S ;
Mosch, D ;
Willoch, F ;
Buch, K ;
Schad, D ;
Schwaiger, M ;
Kurz, A .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1997, 8 (02) :98-104
[7]  
HOLMAN BL, 1992, J NUCL MED, V33, P181
[8]   A NEW CLINICAL-SCALE FOR THE STAGING OF DEMENTIA [J].
HUGHES, CP ;
BERG, L ;
DANZIGER, WL ;
COBEN, LA ;
MARTIN, RL .
BRITISH JOURNAL OF PSYCHIATRY, 1982, 140 (JUN) :566-572
[9]   CEREBRAL PHARMACODYNAMICS OF PHYSOSTIGMINE IN ALZHEIMERS-DISEASE INVESTIGATED USING SINGLE-PHOTON COMPUTERIZED-TOMOGRAPHY [J].
HUNTER, R ;
WYPER, DJ ;
PATTERSON, J ;
HANSEN, MT ;
GOODWIN, GM .
BRITISH JOURNAL OF PSYCHIATRY, 1991, 158 :351-357
[10]   HETEROGENEITY IN ALZHEIMERS-DISEASE - PROGRESSION RATE SEGREGATED BY DISTINCT NEUROPSYCHOLOGICAL AND CEREBRAL METABOLIC PROFILES [J].
MANN, UM ;
MOHR, E ;
GEARING, M ;
CHASE, TN .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1992, 55 (10) :956-959